1. Home
  2. ENIC vs GRFS Comparison

ENIC vs GRFS Comparison

Compare ENIC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ENIC

Enel Chile S.A. (Each representing 50 shares of)

HOLD

Current Price

$3.85

Market Cap

5.3B

Sector

Utilities

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.49

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENIC
GRFS
Founded
2016
1940
Country
Chile
Spain
Employees
N/A
25247
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.8B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ENIC
GRFS
Price
$3.85
$7.49
Analyst Decision
Hold
Hold
Analyst Count
1
2
Target Price
N/A
$10.15
AVG Volume (30 Days)
487.1K
817.0K
Earning Date
03-02-2026
07-28-2022
Dividend Yield
4.69%
1.87%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$96,491.22
$5.33
Revenue Next Year
$2.63
$6.50
P/E Ratio
$101.18
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$2.85
$6.19
52 Week High
$4.51
$11.14

Technical Indicators

Market Signals
Indicator
ENIC
GRFS
Relative Strength Index (RSI) 40.47 30.68
Support Level $3.85 N/A
Resistance Level $3.96 $9.11
Average True Range (ATR) 0.11 0.19
MACD -0.01 -0.02
Stochastic Oscillator 13.31 10.80

Price Performance

Historical Comparison
ENIC
GRFS

About ENIC Enel Chile S.A. (Each representing 50 shares of)

Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: